Patents by Inventor Ling Geng

Ling Geng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240374649
    Abstract: A method for regulating an ILK signaling pathway in a cell, includes administering to the cell exosomes derived from mesenchymal stem cells, in particular mesenchymal stem cells derived from induced pluripotent stem cells. A method is provided for treating ILK signaling pathway related diseases using the exosomes. A pharmaceutical composition is provided for treating ILK signaling pathway related diseases, and includes exosomes derived from mesenchymal stem cells.
    Type: Application
    Filed: September 15, 2022
    Publication date: November 14, 2024
    Inventors: Zijiang CHEN, Jinlong MA, Gang LU, Ruican CAO, Ling GENG, Hongbin LIU, Yueran ZHAO, Yue LV
  • Patent number: 11450309
    Abstract: The present disclosure provides an information processing method, including: acquiring a voice test signal, wherein the voice test signal is used for testing an influence parameter of a specified environment on a voice signal; acquiring a voice feedback signal obtained after the voice test signal is reflected by at least one reflecting object, wherein the at least one reflecting object is located in the specified environment; and estimating the influence parameter of the specified environment on the voice signal based on the voice test signal and the voice feedback signal acquired. In addition, the present disclosure also provides an information processing system, a computer system and a computer readable medium.
    Type: Grant
    Filed: September 29, 2018
    Date of Patent: September 20, 2022
    Assignees: Beijing JingDong ShangKe Information Technology Co., Ltd., Beijing Jingdong Century Trading Co., Ltd.
    Inventor: Ling Geng
  • Publication number: 20210163883
    Abstract: An in vitro culture medium that can be utilized for culturing mammalian embryos, especially early-stage embryos, is provided. The culture medium comprises about 10-200 nM insulin-like growth factor 2 (IGF2). A method for culturing mammalian embryos in vitro is also provided, which substantially includes culturing an early stage embryo of a mammal using the culture medium. The in vitro culture medium and method can increase the formation rate of blastocysts of mammals, particularly humans, and can also improve the quality of embryos, thereby improving the success rate of assisted reproductive technologies. The culture medium and method are particularly useful in culturing embryo from an aged mammal or a mammal with obesity.
    Type: Application
    Filed: February 9, 2021
    Publication date: June 3, 2021
    Inventors: Zijiang CHEN, Hongbin LIU, Yueran ZHAO, Jinlong MA, Ling GENG, Gang LU, Hui LIU, Chuanxin ZHANG, Mengjing LI
  • Publication number: 20200349918
    Abstract: The present disclosure provides an information processing method, including: acquiring a voice test signal, wherein the voice test signal is used for testing an influence parameter of a specified environment on a voice signal; acquiring a voice feedback signal obtained after the voice test signal is reflected by at least one reflecting object, wherein the at least one reflecting object is located in the specified environment; and estimating the influence parameter of the specified environment on the voice signal based on the voice test signal and the voice feedback signal acquired. In addition, the present disclosure also provides an information processing system, a computer system and a computer readable medium.
    Type: Application
    Filed: September 29, 2018
    Publication date: November 5, 2020
    Inventor: Ling GENG
  • Patent number: 8685647
    Abstract: The present invention discloses SNP markers associated with PCOS and provides probes, chips, primers, kits and methods for detecting the SNP markers. Furthermore, the present invention relates to the use of SNPs in predicting or diagnosing the risk of PCOS.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: April 1, 2014
    Assignees: Shandong University, Shandong Shanda Hospital for Reproductive Medicine Co., Ltd., Shanghai Jiao Tong University
    Inventors: Zi-Jiang Chen, Han Zhao, Lin He, Yongyong Shi, Jinlong Ma, Yueran Zhao, Ling Geng, Li You
  • Publication number: 20120309642
    Abstract: The present invention discloses SNP markers associated with PCOS and provides probes, chips, primers, kits and methods for detecting the SNP markers. Furthermore, the present invention relates to the use of SNPs in predicting or diagnosing the risk of PCOS.
    Type: Application
    Filed: June 18, 2012
    Publication date: December 6, 2012
    Inventors: Zi-Jiang CHEN, Han Zhao, Lin He, Yongyong Shi, Jinlong Ma, Yueran Zhao, Ling Geng, Li You
  • Publication number: 20030219785
    Abstract: The identification of radiation-inducible genes by isolating RNA from irradiated cell cultures and then hybridizing the isolated RNA to nucleic acid sequences from an organism of interest (e.g. mammals such as mice and human beings); a method for x-ray guided drug delivery using a targeting ligand that specifically recognizes a radiation-inducible RNA target molecule; and magnetic dispersion of an active agent, such as the dispersion of a genetic construct within a tumor.
    Type: Application
    Filed: January 31, 2003
    Publication date: November 27, 2003
    Applicant: Vanderbilt University
    Inventors: Dennis E. Hallahan, Ling Geng, Todd D. Giorgio